NASHFit: A randomized controlled trial of an exercise training program to reduce clotting risk in patients with NASH-Reference-Cited by-同舟云学术

NASHFit: A randomized controlled trial of an exercise training program to reduce clotting risk in patients with NASH

Published:2022-01-22 Issue: Volume: Page:
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Stine Jonathan G.¹²³⁴^ORCID,Schreibman Ian R.¹³,Faust Alison J.¹³,Dahmus Jessica¹,Stern Benjamin¹,Soriano Christopher¹,Rivas Gloriany¹^ORCID,Hummer Breianna¹^ORCID,Kimball Scot R.⁵,Geyer Nate R.²^ORCID,Chinchilli Vernon M.²,Loomba Rohit⁶⁷^ORCID,Schmitz Kathryn²⁴⁸⁹,Sciamanna Christopher²⁴¹⁰,Strine Cindy,Wentzel Rachel,Marlin Sara,Sica Chris,Vesek Jeff,Eyster Elaine,Sinoway Lawrence,Bentz Kathy,Handley Nancy,Hershey Fell Brenda,Mottilla Shirlynn,Christ Christine,George Susan,Novchich Terry,Beyer Megan,Clarke Kofi,Myers Tiffany,Glading‐Steinruck Martha,Krok Karen,Ma Thomas,Riley Thomas,Thompson Elizabeth,Tressler Heather,Broach James,Doan Trang,Patrick Sue,Reed Syndi,Hamilton Chris,Slavoski Kristin,Tregea Deborah

Affiliation:

1. Division of Gastroenterology and Hepatology Department of Medicine The Pennsylvania State University–Milton S. Hershey Medical Center Hershey Pennsylvania USA

2. Department of Public Health Sciences The Pennsylvania State University–College of Medicine Hershey Pennsylvania USA

3. Liver Center The Pennsylvania State University–Milton S. Hershey Medical Center Hershey Pennsylvania USA

4. Cancer Institute The Pennsylvania State University–Milton S. Hershey Medical Center Hershey Pennsylvania USA

5. Department of Physiology The Pennsylvania State University–College of Medicine Hershey Pennsylvania USA

6. Division of Gastroenterology and Hepatology Department of Medicine University of California San Diego San Diego California USA

7. NAFLD Research Center University of California San Diego San Diego California USA

8. Department of Kinesiology The Pennsylvania State University–College of Medicine Hershey Pennsylvania USA

9. Department of Physical Medicine and Rehabilitation The Pennsylvania State University–Milton S. Hershey Medical Center Hershey Pennsylvania USA

10. Department of Medicine The Pennsylvania State University–Milton S. Hershey Medical Center Hershey Pennsylvania USA

Funder

National Institute of Diabetes and Digestive and Kidney Diseases

National Institutes of Health

Pennsylvania Department of Health

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep.32274

Reference50 articles.

1. Non-alcoholic fatty liver disease – A global public health perspective

2. Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis

3. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases

4. AGA Clinical Practice Update on Screening and Surveillance for Hepatocellular Carcinoma in Patients With Nonalcoholic Fatty Liver Disease: Expert Review

5. Systematic review with meta-analysis: risk of hepatocellular carcinoma in non-alcoholic steatohepatitis without cirrhosis compared to other liver diseases

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Digital therapeutics lead to clinically significant body weight loss in patients with metabolic dysfunction–associated steatotic liver disease: A systematic review and meta-analysis;Hepatology Communications;2024-07-31

2. Letter: Helicobacter pylori and metabolic syndrome‐related von Willebrand factor and plasminogen activator inhibitor‐1 activity levels for outcome prediction of advanced chronic liver disease: Authors' reply;Alimentary Pharmacology & Therapeutics;2024-07-03

3. AMPED study: Protocol for a randomized controlled trial of different doses of aerobic exercise training;Hepatology Communications;2024-06-19

4. Exercise improves surrogate measures of liver histological response in metabolic dysfunction‐associated steatotic liver disease;Liver International;2024-06-07

5. Hepatic Klf10-Fh1 axis promotes exercise-mediated amelioration of NASH in mice;Metabolism;2024-06